作者:Marko Škof、Jurij Svete、Branko Stanovnik、Simona Golič-Grdadolnik
DOI:10.1002/(sici)1522-2675(20000412)83:4<760::aid-hlca760>3.0.co;2-r
日期:2000.4.12
(3E,5S)-1-Benzoyl-5-[(benzoyloxy)methyl]-3-[(dimethylamino)methylidene]pyrrolidin-2-one (9) was prepared in two steps from commercially available (S)-5-(hydroxymethyl)pyrrolidin-2-one (7) (Scheme 1). Compound 9 gave. in one step, upon treatment with various C,N- and C,O-1,3-dinucleophiles 10-18, the corresponding 3-(quinolizin-3-yl)- and 3-(2-oxo-2H-pyran-3-yl)-substituted (2S)-2-(benzoylamino)propyl benzoates 19-27 (Schemes 1 and 2).
(3E,5S)-1-苯甲酰-5-[(苯甲酰氧基)甲基]-3-[(二甲基氨基)亚甲基]吡咯烷-2-酮(9)由商业可得的(S)-5-(羟甲基)吡咯烷-2-酮(7)经两步合成(方案1)。化合物9经一步反应,与各种C,N-和C,O-1,3-二核试剂(10-18)反应,生成相应的3-(喹诺林-3-基)-和3-(2-氧代-2H-吡喃-3-基)-取代的(S)-2-(苯甲酰氨基)丙基苯甲酸酯(19-27)(方案1和2)。